Isolation of multidrug-resistant tuberculosis strains in patients from private and public health care facilities in Nairobi, Kenya

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 7, 2004, Pages 837-841

  Githui, Willie A ^a   Meme, H K ^a   Juma, E S ^a   Kinyanjui, P ^a   Karimi, F ^a   Chakaya, J M ^a,b   Kangangi, J ^b   Kutwa, A ^b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Natl Leprosy/TB Contr Prog Kenya   (Kenya)

Author keywords

Kenya; Multidrug resistant tuberculosis; Nairobi

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEALTH CARE FACILITY; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HEALTH SERVICE; SPUTUM CULTURE; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE; FEMALE; HEALTH FACILITIES; HUMANS; INCIDENCE; KENYA; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 3142751894     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. Anti-tuberculosis drug resistance in the world 1997. WHO/TB/97.229. Geneva, Switzerland: WHO, 1997.
2. Iseman M D. Treatment of multidrug resistant tuberculosis. N Engl J Med 1993: 329: 784-789.
3. Drobniewski F A, Yates M D. Multiple drug resistant tuberculosis. J Clin Pathol 1997; 50: 89-92.
4. Mitchison D A. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 10-15.
5. Fischl M A, Daikos G L, Uttamchandani R B, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 1992; 117: 184-190.
6. Drobniewski E. Is death inevitable with multidrug-resistant TB plus HIV infection? Lancet 1997; 349: 71-72.
7. Salomon N, Perlman D C, Friedmann P, Buchstein S, Kreiswirth B N, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1245-1252.
8. Pablos-Mendez A, Raviglione M C, Lazlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. New Engl J Med 1998; 338: 1641-1649.
9. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. WHO/CDS/TB/2000.278. Geneva, Switzerland: WHO, 2000.
10. Conover R, Ridzon S, Valway L, et al. Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis 2001; 5: 59-64.
11. National Leprosy and Tuberculosis Programme. Annual report. Nairobi, Kenya: Ministry of Health, 2001.
12. Githui W A, Chakaya J M, Meme H, et al. Laboratory facilities for diagnosis of tuberculosis in a slum in Nairobi, Kenya. Durban, South Africa: 14th Conference of the International Union Against Tuberculosis and Lung Disease (IUATLD) Africa Region, 11-14 June 2002. [Abstract].
13. Chakaya J M, Kwamanga D, Githui W A, et al. Tuberculosis knowledge, altitude and practices of private practitioners in an urban slum in Kenya. Durban, South Africa: 14th Conference of the International Union Against Tuberculosis and Lung disease (IUATLD) Africa Region 11-14 June 2002. [Abstract].
14. Githui W. Issues facing TB control: diagnostic issue: problems of diagnostic facilities in developing countries. Scot Med J 2000; 45 (Supp 1): 44-46.
15. Githui W A. Laboratory methods for diagnosis and detection of drug resistant Mycobacterium tuberculosis complex with reference to developing countries: a review. East Afr Med J 2002; 79: 13-19.
16. Githui WA, Juma, E S, van Gorkom J, Kibuga D, Drobniewski F. Antituberculosis Drug Resistance Surveillance in Kenya, 1995. Int J Tuberc Lung Dis. 1998; 2: 499-505.
17. Githui W A, Hawken M, Juma E S, et al. Surveillance of drug resistant tuberculosis and molecular transmission of resistant strains in refugee in refugee and non refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis 2000; 2: 235-241.
18. Victor T C, Jordaan A M, van Rie A, et al. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Int J Tuberc Lung Dis 1999; 79: 343-348.
19. Githui W A, Jordaan A M, Juma E S, et al. Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int J Tuberc Lung Dis 2004; 8: 352-360.
20. Teixeira L, Perkins M D, Johnson J L, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2001; 5: 321-328.
21. Gupta R, Kim J Y, Espinal M A, et al. Responding to market failures in tuberculosis control. Science 2001; 293: 1049-1051.